CNN Health: Bioliefife, the medical device company, is developing a new way to give blood plasma for the first time, but only with donated dog food.
The company announced today that it has raised $10 million from investors and will begin donating the blood plasma in the next three to four weeks.
The blood plasma can be given to a dog through a blood bank or can be made into a plasma capsule.
There is no price cap on the plasma.
The technology is still in its early stages and Biolifeife has no plans to sell the plasma to the general public, according to co-founder and chief scientific officer Peter Wozniak.
It will instead use the plasma for research and development, the company said.
The product is also being used in an experimental therapy that was developed at Duke University to treat blood clots.
The Duke study was a trial that found a combination of a small amount of the plasma and diet can reduce the risk of clotting.
This is not a new approach to plasma donation.
Companies such as Bioscience and Transplantable Organ Systems have already developed other methods of giving blood plasma, including a capsule that is infused with a small, thin, bio-compatible polymer.
A smaller, more portable version of this technology is being developed by a team at Johns Hopkins University in Baltimore.
This story was updated at 11:18 a.m.